US2009035875A1PendingUtilityA1

Cytochrome C And Leucine-Rich Alpha-2-Glycoprotein-1 Assays, Methods, And Antibodies

33
Individually held — no corporate assignee on recordPriority: Jan 25, 2006Filed: Jul 24, 2008Published: Feb 5, 2009
Est. expiryJan 25, 2026(expired)· nominal 20-yr term from priority
Inventors:Ronald R. Jemmerson
G01N 2333/80G01N 33/566G01N 2400/00
33
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates generally to assays and methods involving Cytochrome c (Cyt c) and leucine-rich alpha-2-glycoprotein-1 (LRG), and related antibodies. In an embodiment, the invention includes an isolated antibody produced by a hybridoma cell line having ATCC Accession Number PTA-8131, or antibody fragment thereof that specifically binds to leucine-rich alpha-2-glycoprotein-1. In an embodiment, the invention includes a hybridoma cell line producing such an antibody or antibody fragment. In an embodiment, the invention includes a kit including such an antibody. Other embodiments are included herein.

Claims

exact text as granted — not AI-modified
1 . An isolated antibody produced by a hybridoma cell line having ATCC Accession Number PTA-8131, or antibody fragment thereof that specifically binds to leucine-rich alpha-2-glycoprotein-1. 
     
     
         2 . A hybridoma cell line producing the isolated antibody of  claim 1 . 
     
     
         3 . A kit comprising an isolated antibody produced by a hybridoma cell line having ATCC Accession Number PTA-8131, or an antibody fragment thereof that specifically binds to leucine-rich alpha-2-glycoprotein-1, and a compartment, wherein the antibody or fragment is contained within the compartment. 
     
     
         4 . The kit of  claim 3 , further comprising Cytochrome c.

Join the waitlist — get patent alerts

Track US2009035875A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.